HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression

被引:40
作者
Cartron, Pierre-Francois [1 ,2 ]
Blanquart, Christophe [2 ,3 ]
Hervouet, Eric [1 ,2 ]
Gregoire, Marc [2 ,3 ]
Vallette, Francois M. [1 ,2 ,4 ]
机构
[1] INSERM, Ctr Rech Cancerol Nantes Angers, Equipe Apoptose & Progress Tumorale, Equipe Labellisee Ligue Natl Canc,U892, F-44007 Nantes 1, France
[2] Univ Nantes, Fac Med, Dept Rech Cancerol, IFR26, F-4400 Nantes, France
[3] INSERM, Ctr Rech Cancerol Nantes Angers, Equipe Biol Cellules Dendrit Applicat Immunothera, U892, F-44007 Nantes 1, France
[4] Inst Cancerol Ouest, LaBCT, F-44805 Nantes, Saint Herblain, France
关键词
Dnmt; Epigenetic; HDAC; NY-ESO1; Glioma; Mesothelioma; DNA METHYLATION; ANTIGEN-EXPRESSION; VALPROIC ACID; CELLS; MESOTHELIOMA; INHERITANCE; GLIOMA; TUMORS; DNMT1; HDAC1;
D O I
10.1016/j.molonc.2012.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NY-ESO1 gene is a cancer/testis antigen considered to be suitable target for the immunotherapy of human malignancies. Despite the identification of the epigenetical silencing of the NY-ESO1 gene in a large variety of tumors, the molecular mechanism involved in this phenomenon is not fully elucidated. In two non epithelial cancers (glioma and mesothelioma), we found that the epigenetic regulation of the NY-ESO1 gene requires the sequential recruitment of the HDAC1-mSin3a-NCOR, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a complexes. Thus, our data illustrate the orchestration of a sequential epigenetic mechanism including the histone deacetylation and methylation, and the DNA methylation processes. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:452 / 463
页数:12
相关论文
共 26 条
[1]  
Bostick M, 2007, SCIENCE, V27, P2187
[2]   Cancer/testis antigen expression in human mesenchymal stem cells:: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression [J].
Cronwright, G ;
Le Blanc, K ;
Götherström, C ;
Darcy, P ;
Ehnman, M ;
Brodin, B .
CANCER RESEARCH, 2005, 65 (06) :2207-2215
[3]   Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation [J].
Dovey, Oliver M. ;
Foster, Charles T. ;
Cowley, Shaun M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (18) :8242-8247
[4]   Antitumor Effects of a Combined 5-Aza-2′Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice [J].
Ecke, Ines ;
Petry, Frauke ;
Rosenberger, Albert ;
Tauber, Svantje ;
Moenkemeyer, Sven ;
Hess, Ina ;
Dullin, Christian ;
Kimmina, Sarah ;
Pirngruber, Judith ;
Johnsen, Steven A. ;
Uhmann, Anja ;
Nitzki, Frauke ;
Wojnowski, Leszek ;
Schulz-Schaeffer, Walter ;
Witt, Olaf ;
Hahn, Heidi .
CANCER RESEARCH, 2009, 69 (03) :887-895
[5]   Histone methylation: a dynamic mark in health, disease and inheritance [J].
Greer, Eric L. ;
Shi, Yang .
NATURE REVIEWS GENETICS, 2012, 13 (05) :343-357
[6]   Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth [J].
Guillot, Flora ;
Boutin, Benoit ;
Blanquart, Christophe ;
Fonteneau, Jean-Francois ;
Robard, Myriam ;
Gregoire, Marc ;
Pouliquen, Daniel .
VACCINE, 2011, 29 (33) :5534-5543
[7]  
Hegi M., 2005, NEW ENGL J MED, V352, P991
[8]  
Hervouet E, 2009, EPIGENETICS, V4
[9]  
Hervouet E., 2010, CELL DEATH DIS, V1
[10]  
Hervouet Eric, 2010, Genes Cancer, V1, P434, DOI 10.1177/1947601910373794